Business Wire

JEONJU-CITY

Share
Jeonju Bibimbap Festival 2022 to be Held as Genuine Cultural Food Festival

Jeonju, a city of gastronomy, will host Jeonju Bibimbap Festival 2022, a representative cultural food festival of Korea, from October 6 to 10 in the vicinity of Jeonju Hyanggyo in Jeonju Hanok Village. Under the theme of Bibimbap, the event will offer a wide range of local dishes along with cultural performances.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005035/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Jeonju Bibimbap Festival 2022 opens as a genuine cultural food festival from October 6 to 10 in the vicinity of Jeonju Hyanggyo in Jeonju Hanok Village under the theme of Bibimbap with various local dishes along with cultural performances. (Graphic: Business Wire)

The opening ceremony, 'Gaematshik,' which means “opening the taste of Jeonju,” will be started with pre-events including 'Hyanggyo-gil B-boy Contest' and 'Bibap Race.' It will be followed by 'Bibap Art Wall,' a display of an art wall created using Bibimbap ingredients, 'Bibapcon,' a congratulatory performance by a fusion Korean traditional music group, 'Bibim Gimbap Contest,' a new-concept contest proposed by the festival, and 'Bibap Archiving Exhibition.'

The key programs of the festival are 'Bibap Picnic,' a picnic at Jeonju Hyanggyo, 'Bibap Party' to enjoy finger food and drinks with music mixed by a DJ, 'Bimaek Party,' a party to enjoy dishes with beer, 'Bibap Theater' to watch movies using wireless headsets, and 'Bibap Table,' a row of food stalls on Dongmun-gil.

The event will also offer around 20 standing programs to please the eyes, ears, and tastebuds of Jeonju citizens and tourists.

Jeonju’s tastes can be enjoyed at 'Stories of Jeonju Food Masters,' an opportunity to meet with Jeonju’s food experts, reputed families, and next-generation masters, 'Insaeng Matchan' to prepare dishes only for a single couple, 'Bibap Restaurant' serving Bibim dishes developed for Jeonju Bibimbap Festival, 'Bibap Jumak,' a tavern with Generation MZ chefs prepared dishes, 'Bibap Food Court,' a street food zone serving a variety of menus, and 'Parasol Tables' installed along a street by the stream.

A range of entertainment programs including a crafts flea market, a parade performance, an exhibition of tableware created by master craftsmen, and experience, game, and event zones for tourists will also be available.

“We will develop this event into a safe and healthy local festival model by operating programs based on cooperation with local residents and small businesses to comply with the COVID-19 quarantine regulations,” said a Jeonju City official. “We invite everyone to the festival to enjoy Jeonju’s food and culture.”

The key programs of Jeonju Bibimbap Festival 2022 will be held on a reservation basis. For details, contact Jeonju Bibimbap Festival Secretariat (Tel.: +82-63-283-1141).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220927005035/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

FieldBee Vision wins Gold for Digital Technology Innovation at LAMMA 20269.1.2026 05:25:00 CET | Press release

FieldBee, the European leader in high-quality, easy-to-use and affordable precision agriculture technologies, proudly announces that FieldBee Vision has earned global recognition, becoming the Gold Winner in the Digital Technology Innovation of the Year category at the LAMMA Innovation Awards 2026. Lamma Show is the UK’s premier agricultural machinery, technology and equipment innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107606411/en/ FieldBee wins the LAMMA Innovation Award 2026 for Digital Technology Innovation of the Year for the FieldBee Vision (VisionSteer & VisionPro) system FieldBee Vision is part of the newly launched myFieldBee ecosystem, built to unify FieldBee’s precision farming tools and designed to connect navigation, autosteering, ISOBUS into one unified platform that supports planning, execution, monitoring and reporting. FieldBee Vision, the first modular retrofit agricultural vision system,

Survey Finds Over 70% of Chinese Doctors Recommend “AI Doctor Services” Like Ant Group’s AQ for Everyday Health Needs9.1.2026 04:31:00 CET | Press release

A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) hospitals, more than 70% said they would recommend AI doctor services to patients for everyday health questions and routine health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108456917/en/ Ant Group’s AI-native health app AQ is designed to address common, everyday health concerns and support healthy habit formation. Ant Group’s AQ was the most frequently recommended platform in the survey. The latest figures show that, as of January 2026, the app had accumulated 30 million monthly active users and answers over 10 million health-related questions daily, making it China’s leading AI-native health app. AQ—known in Chinese as Ant A-Fu—is an AI-native health app launched by Ant Group in June 2025. Desig

OPPO Joins VVC Advance Patent Pool as a Licensee and Extends HEVC Advance License9.1.2026 03:00:00 CET | Press release

Access Advance LLC and Guangdong OPPO Mobile Telecommunications Corp., Ltd. (OPPO) today announced that OPPO has joined the VVC Advance Patent Pool as a Licensee and renewed its HEVC Advance License. OPPO, one of the world's largest smartphone manufacturers with operations in more than 70 countries, has been a valued participant in Access Advance's HEVC patent pool since 2020, and more recently joined the Advance Video Distribution Patent (VDP) Pool as a Licensor. These latest agreements mark a new milestone in a broad and deepening relationship between the two companies, with OPPO now participating across all three of Access Advance's video codec licensing programs. The VVC Advance Patent Pool licenses patents essential to the VVC/H.266 standard, which delivers remarkable improvement of video compression performance over HEVC, enabling higher-quality video experiences including 4K, 8K, and HDR content with faster downloads and lower latency. The pool currently includes over 4,500 worl

Cessna Citation CJ3 Gen2 Enters Into Service, Delivering the Most Significant Gen2 Updates to Date8.1.2026 22:30:00 CET | Press release

The Cessna Citation CJ3 Gen2 has entered into service, setting a new standard for the Citation Gen2 family. Launch customers and longtime Citation owners Dave Mecartney and Shannon Day took delivery of their new aircraft this week. Mecartney—an experienced aviator with nearly two decades flying Citation light jets and a member of Textron Aviation’s Customer Advisory Board—helped shape the enhancements that elevate the CJ3 Gen2 experience. Key upgrades include Garmin autothrottle technology, added pilot legroom and a fully customizable cabin environment, all driven by customer feedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108455097/en/ Cessna Citation CJ3 Gen2 enters into service, delivering the most significant Gen2 updates to date (Photo credit: Textron Aviation). The Cessna Citation CJ3 Gen2 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “The Citation CJ3 Gen2 deliv

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye